485 related articles for article (PubMed ID: 23867710)
21. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.
Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL
PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.
Szmida E; Karpiński P; Leszczynski P; Sedziak T; Kielan W; Ostasiewicz P; Sasiadek MM
J Appl Genet; 2015 May; 56(2):185-92. PubMed ID: 25366420
[TBL] [Abstract][Full Text] [Related]
23. Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
Boot A; Oosting J; van Eendenburg JDH; Kuppen PJK; Morreau H; van Wezel T
PLoS One; 2017; 12(9):e0184900. PubMed ID: 28931069
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays.
Li H; Du Y; Zhang D; Wang LN; Yang C; Liu B; Wang WJ; Shi L; Hong WG; Zhang L; Yang YX
Oncol Rep; 2012 Jul; 28(1):99-104. PubMed ID: 22552777
[TBL] [Abstract][Full Text] [Related]
25. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.
Simmer F; Brinkman AB; Assenov Y; Matarese F; Kaan A; Sabatino L; Villanueva A; Huertas D; Esteller M; Lengauer T; Bock C; Colantuoni V; Altucci L; Stunnenberg HG
Epigenetics; 2012 Dec; 7(12):1355-67. PubMed ID: 23079744
[TBL] [Abstract][Full Text] [Related]
26. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
[No Abstract] [Full Text] [Related]
27. A genome-wide DNA methylation study in colorectal carcinoma.
Kibriya MG; Raza M; Jasmine F; Roy S; Paul-Brutus R; Rahaman R; Dodsworth C; Rakibuz-Zaman M; Kamal M; Ahsan H
BMC Med Genomics; 2011 Jun; 4():50. PubMed ID: 21699707
[TBL] [Abstract][Full Text] [Related]
28. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer.
Lange CP; Campan M; Hinoue T; Schmitz RF; van der Meulen-de Jong AE; Slingerland H; Kok PJ; van Dijk CM; Weisenberger DJ; Shen H; Tollenaar RA; Laird PW
PLoS One; 2012; 7(11):e50266. PubMed ID: 23209692
[TBL] [Abstract][Full Text] [Related]
29. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
30. Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed, paraffin-embedded paired tumor and normal tissue.
Jasmine F; Rahaman R; Roy S; Raza M; Paul R; Rakibuz-Zaman M; Paul-Brutus R; Dodsworth C; Kamal M; Ahsan H; Kibriya MG
BMC Res Notes; 2012 Feb; 5():117. PubMed ID: 22357164
[TBL] [Abstract][Full Text] [Related]
31. Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profiles.
He C; Huang Q; Zhong S; Chen LS; Xiao H; Li L
World J Surg Oncol; 2023 Oct; 21(1):312. PubMed ID: 37779184
[TBL] [Abstract][Full Text] [Related]
32. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
[TBL] [Abstract][Full Text] [Related]
33. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
35. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
36. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.
Sharma P; Bhunia S; Poojary SS; Tekcham DS; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
Tumour Biol; 2016 Nov; 37(11):14687-14699. PubMed ID: 27623942
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer.
Moon JW; Lee SK; Lee JO; Kim N; Lee YW; Kim SJ; Kang HJ; Kim J; Kim HS; Park SH
J Exp Clin Cancer Res; 2014 Jan; 33(1):4. PubMed ID: 24393480
[TBL] [Abstract][Full Text] [Related]
38. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features.
Ang PW; Loh M; Liem N; Lim PL; Grieu F; Vaithilingam A; Platell C; Yong WP; Iacopetta B; Soong R
BMC Cancer; 2010 May; 10():227. PubMed ID: 20492682
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
Namba S; Sato K; Kojima S; Ueno T; Yamamoto Y; Tanaka Y; Inoue S; Nagae G; Iinuma H; Hazama S; Ishihara S; Aburatani H; Mano H; Kawazu M
Cancer Sci; 2019 Mar; 110(3):1096-1104. PubMed ID: 30637877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]